XRCC1 Polymorphisms and urinary 8-hydroxydeoxyguanine levels are associated with urothelial carcinoma

Chien I. Chiang, Ya-Li Huang, Chao Yuan Huang, Horng Sheng Shiue, Wei Jen Chen, Yeong Shiau Pu, Ying-Chin Lin, Yu-Mei Hsueh

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

The aim of this study was to examine the associations between the combined effects of urinary 8-Hydroxydeoxyguanine (8-OHdG) level and polymorphisms of XRCC1 Arg194Trp and XRCC1 Arg399Gln on the risk of urothelial carcinoma (UC). We conducted a hospitalbased case-control study that included 168 cases of UC and 336 age- and gender-matched healthy controls. We used polymerase chain reaction and restriction fragment length polymorphism analyses to examine the genotypes of XRCC1 Arg194Trp and XRCC1 Arg399Gln. We used a competitive in vitro enzyme-linked immunosorbent assay to determine urinary 8-OHdG levels. The XRCC1 399 Gln/Gln genotype and the XRCC1194 Arg/ Arg genotype were positively correlated to UC (OR [95%CI] = 2.27 [1.20-4.27] and 1.59 [1.06 -2.36], respectively). Urinary 8-OHdG levels were associated with UC in a dose-dependent manner. Participants with the XRCC1 (Arg399Gln) Gln/Gln genotype or the G-C/AC haplotype of XRCC1 and a high urinary 8-OHdG level had a significantly higher risk of UC than those with the Arg/Arg + Arg/Gln genotype or the G-T haplotype and a low urinary 8- OHdG level. This is the first study to investigate the combined effect of urinary 8-OHdG level and XRCC1 polymorphisms on UC risk. The findings are especially meaningful for participants with XRCC1 399Gln or XRCC1 Arg194 genotypes and a high urinary 8-OHdG level, since these variables are associated with an increased risk of UC.
原文英語
文章編號e0124066
期刊PLoS One
10
發行號5
DOIs
出版狀態已發佈 - 五月 4 2015

指紋

Polymorphism
carcinoma
genetic polymorphism
Carcinoma
Genotype
genotype
Immunosorbents
Polymerase chain reaction
Haplotypes
haplotypes
Assays
8-oxo-7,8-dihydrodeoxyguanine
case-control studies
Restriction Fragment Length Polymorphisms
Enzymes
Case-Control Studies
restriction fragment length polymorphism
polymerase chain reaction
Enzyme-Linked Immunosorbent Assay
enzyme-linked immunosorbent assay

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

引用此文

XRCC1 Polymorphisms and urinary 8-hydroxydeoxyguanine levels are associated with urothelial carcinoma. / Chiang, Chien I.; Huang, Ya-Li; Huang, Chao Yuan; Shiue, Horng Sheng; Chen, Wei Jen; Pu, Yeong Shiau; Lin, Ying-Chin; Hsueh, Yu-Mei.

於: PLoS One, 卷 10, 編號 5, e0124066, 04.05.2015.

研究成果: 雜誌貢獻文章

Chiang, Chien I. ; Huang, Ya-Li ; Huang, Chao Yuan ; Shiue, Horng Sheng ; Chen, Wei Jen ; Pu, Yeong Shiau ; Lin, Ying-Chin ; Hsueh, Yu-Mei. / XRCC1 Polymorphisms and urinary 8-hydroxydeoxyguanine levels are associated with urothelial carcinoma. 於: PLoS One. 2015 ; 卷 10, 編號 5.
@article{c14a812866924362931ca570d5ee1bcb,
title = "XRCC1 Polymorphisms and urinary 8-hydroxydeoxyguanine levels are associated with urothelial carcinoma",
abstract = "The aim of this study was to examine the associations between the combined effects of urinary 8-Hydroxydeoxyguanine (8-OHdG) level and polymorphisms of XRCC1 Arg194Trp and XRCC1 Arg399Gln on the risk of urothelial carcinoma (UC). We conducted a hospitalbased case-control study that included 168 cases of UC and 336 age- and gender-matched healthy controls. We used polymerase chain reaction and restriction fragment length polymorphism analyses to examine the genotypes of XRCC1 Arg194Trp and XRCC1 Arg399Gln. We used a competitive in vitro enzyme-linked immunosorbent assay to determine urinary 8-OHdG levels. The XRCC1 399 Gln/Gln genotype and the XRCC1194 Arg/ Arg genotype were positively correlated to UC (OR [95{\%}CI] = 2.27 [1.20-4.27] and 1.59 [1.06 -2.36], respectively). Urinary 8-OHdG levels were associated with UC in a dose-dependent manner. Participants with the XRCC1 (Arg399Gln) Gln/Gln genotype or the G-C/AC haplotype of XRCC1 and a high urinary 8-OHdG level had a significantly higher risk of UC than those with the Arg/Arg + Arg/Gln genotype or the G-T haplotype and a low urinary 8- OHdG level. This is the first study to investigate the combined effect of urinary 8-OHdG level and XRCC1 polymorphisms on UC risk. The findings are especially meaningful for participants with XRCC1 399Gln or XRCC1 Arg194 genotypes and a high urinary 8-OHdG level, since these variables are associated with an increased risk of UC.",
author = "Chiang, {Chien I.} and Ya-Li Huang and Huang, {Chao Yuan} and Shiue, {Horng Sheng} and Chen, {Wei Jen} and Pu, {Yeong Shiau} and Ying-Chin Lin and Yu-Mei Hsueh",
year = "2015",
month = "5",
day = "4",
doi = "10.1371/journal.pone.0124066",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - XRCC1 Polymorphisms and urinary 8-hydroxydeoxyguanine levels are associated with urothelial carcinoma

AU - Chiang, Chien I.

AU - Huang, Ya-Li

AU - Huang, Chao Yuan

AU - Shiue, Horng Sheng

AU - Chen, Wei Jen

AU - Pu, Yeong Shiau

AU - Lin, Ying-Chin

AU - Hsueh, Yu-Mei

PY - 2015/5/4

Y1 - 2015/5/4

N2 - The aim of this study was to examine the associations between the combined effects of urinary 8-Hydroxydeoxyguanine (8-OHdG) level and polymorphisms of XRCC1 Arg194Trp and XRCC1 Arg399Gln on the risk of urothelial carcinoma (UC). We conducted a hospitalbased case-control study that included 168 cases of UC and 336 age- and gender-matched healthy controls. We used polymerase chain reaction and restriction fragment length polymorphism analyses to examine the genotypes of XRCC1 Arg194Trp and XRCC1 Arg399Gln. We used a competitive in vitro enzyme-linked immunosorbent assay to determine urinary 8-OHdG levels. The XRCC1 399 Gln/Gln genotype and the XRCC1194 Arg/ Arg genotype were positively correlated to UC (OR [95%CI] = 2.27 [1.20-4.27] and 1.59 [1.06 -2.36], respectively). Urinary 8-OHdG levels were associated with UC in a dose-dependent manner. Participants with the XRCC1 (Arg399Gln) Gln/Gln genotype or the G-C/AC haplotype of XRCC1 and a high urinary 8-OHdG level had a significantly higher risk of UC than those with the Arg/Arg + Arg/Gln genotype or the G-T haplotype and a low urinary 8- OHdG level. This is the first study to investigate the combined effect of urinary 8-OHdG level and XRCC1 polymorphisms on UC risk. The findings are especially meaningful for participants with XRCC1 399Gln or XRCC1 Arg194 genotypes and a high urinary 8-OHdG level, since these variables are associated with an increased risk of UC.

AB - The aim of this study was to examine the associations between the combined effects of urinary 8-Hydroxydeoxyguanine (8-OHdG) level and polymorphisms of XRCC1 Arg194Trp and XRCC1 Arg399Gln on the risk of urothelial carcinoma (UC). We conducted a hospitalbased case-control study that included 168 cases of UC and 336 age- and gender-matched healthy controls. We used polymerase chain reaction and restriction fragment length polymorphism analyses to examine the genotypes of XRCC1 Arg194Trp and XRCC1 Arg399Gln. We used a competitive in vitro enzyme-linked immunosorbent assay to determine urinary 8-OHdG levels. The XRCC1 399 Gln/Gln genotype and the XRCC1194 Arg/ Arg genotype were positively correlated to UC (OR [95%CI] = 2.27 [1.20-4.27] and 1.59 [1.06 -2.36], respectively). Urinary 8-OHdG levels were associated with UC in a dose-dependent manner. Participants with the XRCC1 (Arg399Gln) Gln/Gln genotype or the G-C/AC haplotype of XRCC1 and a high urinary 8-OHdG level had a significantly higher risk of UC than those with the Arg/Arg + Arg/Gln genotype or the G-T haplotype and a low urinary 8- OHdG level. This is the first study to investigate the combined effect of urinary 8-OHdG level and XRCC1 polymorphisms on UC risk. The findings are especially meaningful for participants with XRCC1 399Gln or XRCC1 Arg194 genotypes and a high urinary 8-OHdG level, since these variables are associated with an increased risk of UC.

UR - http://www.scopus.com/inward/record.url?scp=84929093473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929093473&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0124066

DO - 10.1371/journal.pone.0124066

M3 - Article

C2 - 25938407

AN - SCOPUS:84929093473

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0124066

ER -